2. JAK/STAT Signaling Protein Tyrosine Kinase/RTK Apoptosis
  3. EGFR Apoptosis
  4. EGFR-IN-44

EGFR-IN-44 (Compound 6a) 是一种有效的、具有口服活性的 EGFR tyrosine kinase 抑制剂，其 IC50 值为 4.11 nM。EGFR-IN-44 诱导细胞凋亡 (apoptosis)，口服生物利用度为33.57%。EGFR-IN-44 可以用于非小细胞肺癌的研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

EGFR-IN-44 Chemical Structure

EGFR-IN-44 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

EGFR-IN-44 相关抗体

Top Publications Citing Use of Products

查看 EGFR 亚型特异性产品:

查看所有亚型
EGFR/ErbB1/HER1 ErbB2/HER2 ErbB3/HER3 ErbB4/HER4

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

EGFR-IN-44 (Compound 6a) is a potent, orally active EGFR tyrosine kinase inhibitor with an IC50 of 4.11 nM. EGFR-IN-44 induces cell apoptosis and shows an oral bioavailability value of 33.57%. EGFR-IN-44 can be studied for non-small-cell lung cancers[1].

IC50 & Target

IC50: 0.26 nM (EGFR T790M/L858R), 1.33 nM (EGFR L858R), 4.11 nM (EGFR)[1]
体外研究
(In Vitro)

EGFR-IN-44 (Compound 6a) (0-10 µM, 72 h) shows anti-proliferative activities against tumor cell lines[1].
EGFR-IN-44 binds to the ATP binding site of EGFR[1].
EGFR-IN-44 (0-10 nM, 48 h) induces H1975 cell apoptosis via the mitochondrial pathway, arrests cell cycle in G0/G1 phase, and suppresses cell migration[1].
EGFR-IN-44 (0-10 nM, 48 and 72h) shows hypotoxicity against normal cells[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

EGFR-IN-44 相关抗体:

Cell Proliferation Assay[1]

Cell Line: H1975 (EGFRT790M/L858R), PC9 (EGFRdel19), and H292 (EGFRWT)
Concentration: 0-10 µM
Incubation Time: 72 h
Result: Showed anti-proliferative activities with IC50 values of 0.0022 ± 0.001, 0.0048 ± 0.001, and 4.499 ± 0.057 µM against H1975, PC9, and H292 cells, respectively.

Apoptosis Analysis[1]

Cell Line: H1975
Concentration: 1, 5, and 10 nM
Incubation Time: 48 h
Result: Effectively induced cell apoptosis in a dose-dependent manner. Resulted in 33.7%, 52.4%, and 56.2% apoptosis at 1, 5, and 10 µM, respectively, compared to 5.81% apoptosis in the control group.

Western Blot Analysis[1]

Cell Line: H1975
Concentration: 5, 10, and 25 nM
Incubation Time: 48 h and 72 h
Result: Dose-dependently upregulated the expression levels of the proapoptotic proteins Bad and Bax and downregulated the expression level of the antiapoptotic protein Bcl-2. Sufficiently reduced the phosphorylation of EGFR and AKT.

Cell Cycle Analysis[1]

Cell Line: H1975
Concentration: 5 nM
Incubation Time: 0, 12, 24, or 48 h
Result: Exhibited a significant increase in the G0/G1 cell population and a dramatic decrease in G2/M phase.

Cell Cytotoxicity Assay[1]

Cell Line: LO2, HK2, HLF, and 293A
Concentration: 0.1, 1, 5, and 10 µM
Incubation Time: 48 h and 72 h
Result: Showed hypotoxicity with IC50 values of 7.247, 4.586, 3.787, and 2.925 µM against LO2, HK2, HLF, and 293A cells, respectively. The cell morphology was changed compared to the control.
体内研究
(In Vivo)

EGFR-IN-44 (Compound 6a) (25 mg/kg; i.g.; daily, 7days) shows strong antitumor activity without obvious toxicity[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/c nude mice (5 weeks old, 18 - 20 g), H1975 xenograft model[1]
Dosage: 25 mg/kg
Administration: Intragastric administration, daily, 7 days
Result: Showed strong tumor inhibition (TGI = 90.24%) without obvious toxicity.
Animal Model: Male Sprague–Dawley (SD) rats[1]
Dosage: 1 mg/kg and 5 mg/kg
Administration: Intravenous injection and oral administration (Pharmacokinetic Analysis)
Result: In Vivo PK parameters of EGFR-IN-44 [1]
Parameters
Dose(mg/kg)		 EGFR-IN-44
5 (po)
1 (iv)
t1/2 (h) 8.60 ± 1.8 1.42 ± 0.1
Tmax (h) 4.00 ± 0.002 /
Cmax (ng/mL) 80.40 ± 2.7 /
Vz F_pred (L/kg) 220.80 ± 41.2 6.83 ± 08
AUC0-t (H.ng/mL) 490.41 ± 29.9 291.91 ± 38.2
AUC0-∞ (H.ng/mL) 491.02 ± 44.2 295.76 ± 38.8
MRT0-last (h) 7.93 ± 0.8 1.35 ± 01
CL (mL/h/kg) 17.79 ± 3.9 3.12 ± 0.4
F(%) 33.57 ± 5.9 /

F = (AUC0-inf-PO × DOSEIV)/(AUC0-inf-IV × DOSE PO)*100%.
分子量

537.08

Formula

C27H29ClN6O2S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

EGFR-IN-44 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

EGFR-IN-44EGFRApoptosisEpidermal growth factor receptorErbB-1HER1H1975AKTBcl-2BaxBadBALB/c nude micenon-small-cell lung cancers NSCLCInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
EGFR-IN-44
目录号：
HY-145844
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z